Study: Drug cocktail for advanced breast cancer can extend life up to 16 months

September 29, 2014 6:43 PM

3 0

Study: Drug cocktail for advanced breast cancer can extend life up to 16 months

"We’ve never seen anything like this before," said Dr. Sandra M. Swain, an oncologist at MedStar Washington Hospital Center in D.C.

The drug, Perjeta, was tested on 808 women from all over the world with late-stage metastatic breast cancer. Half the patients took a regimen of cancer drugs, including Perjeta, Herceptin and the chemotherapy drug docetaxel. The other half, the control group, took Herceptin, docetaxel and a placebo ...

Read more

To category page

Loading...